Current concepts in the etiology and treatment of Behçet disease
C Evereklioglu - Survey of ophthalmology, 2005 - Elsevier
Behçet disease is an idiopathic, multisystem, chronic, and recurrent disease characterized
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …
Behçet's disease–a contemporary review
D Mendes, M Correia, M Barbedo, T Vaio, M Mota… - Journal of …, 2009 - Elsevier
Behçet's disease (BD) is a systemic vasculitis disorder of unknown etiology, characterized
by relapsing episodes of oral aphthous ulcers, genital ulcers, skin lesions and ocular …
by relapsing episodes of oral aphthous ulcers, genital ulcers, skin lesions and ocular …
2018 update of the EULAR recommendations for the management of Behçet's syndrome
G Hatemi, R Christensen, D Bang, B Bodaghi… - Annals of the …, 2018 - ard.bmj.com
Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …
EULAR recommendations for the management of Behçet disease
Objectives: To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for the management of Behçet disease (BD) supplemented where …
recommendations for the management of Behçet disease (BD) supplemented where …
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
A Amadi-Obi, CR Yu, X Liu, RM Mahdi, GL Clarke… - Nature medicine, 2007 - nature.com
T-helper type 17 cells (TH17) are implicated in rodent models of immune-mediated
diseases. Here we report their involvement in human uveitis and scleritis, and validate our …
diseases. Here we report their involvement in human uveitis and scleritis, and validate our …
[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative
Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …
based recommendations for the treatment of noninfectious uveitis in the era of biologics …
Behcet's disease
MS Kurokawa, H Yoshikawa… - Seminars in respiratory …, 2004 - thieme-connect.com
Behçet's disease (BD) is a systemic disorder characterized by recurrent attacks of acute
inflammation. Major symptoms are oral aphthous ulcers, uveitis, skin lesions, and genital …
inflammation. Major symptoms are oral aphthous ulcers, uveitis, skin lesions, and genital …
Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations
Y Ozguler, P Leccese, R Christensen… - …, 2018 - academic.oup.com
Objective To assess the efficacy and safety of treatment modalities for major organ
involvement of Behçet's syndrome (BS), in order to inform the update of the EULAR …
involvement of Behçet's syndrome (BS), in order to inform the update of the EULAR …
Update on the therapy of Behçet disease
Z Saleh, T Arayssi - Therapeutic advances in chronic …, 2014 - journals.sagepub.com
Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing
and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and …
and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and …
Treatment of Behçet's disease: an algorithmic multidisciplinary approach
Behçet's disease (BD) is a chronic, relapsing inflammatory, multisystem disease of unknown
etiology. The disease has a wide clinical spectrum of mucocutaneous lesions and ocular …
etiology. The disease has a wide clinical spectrum of mucocutaneous lesions and ocular …